Ann: Appendix 4C - quarterly, page-45

From the perspective of an individual, non-shareholding, cancer patient, what reward is there exactly? Besides the desire to act in the interest of the greater good, without any monetary incentives, ask yourself would you want to participate in a such a study after you've just recently been diagnosed with cancer? They've already been diagnosed, why would you assume there is such a reward for them personally, disregarding the reward to society, to enroll into a study on cancer diagnosis?!

From the perspective of management, there would have been no way to know that we would struggle to enroll patients before the enrollment process began. They now obviously recognize that there is a problem, and as Bob said they will be taking measures to address this issue and hopefully still meet the deadline of having results by end of year.

Agree with other shareholders that a financial incentive would make this a lot easier. I am sure that the company will pursue all avenues they can in the event that we really cannot attract enrollments without providing any other incentive.

People thinking of panic selling on this quarterly, and potentially locking in losses, need to consider for themselves whether this will look like a good decision when the trial inevitably gets underway, and results of the trial are released.

Just because it's been four months doesn't mean the first enrollment can't happen next week.

All IMO.